A Blackpool doctor who has helped to pioneer clinical research in the resort is to be celebrated for his work.
Dr Jerome Kerrane, a partner at Layton Medical Centre, has been invited to join other leading medics at a celebration of the National Institute of Hospital Research in London.
The GP has been involved in research into conditions ranging from pulmonary diseases to depression, and arthritis to vaccinations, and has worked as principal investigator in a number of studies, in his drive to improve medicine for patients.
He said: “Blackpool patients, with all of the poor health that Blackpool has, have access to cutting edge medicines and technologies by way of clinical trials.
“The thing about Blackpool is that there is a lot of disease prevalent, because of lifestyles and deprivation, but we are research active to tackle this.
“Research into new treatments, with the ageing population and society’s increasingly complex health needs, is important.
“Over the years I’ve had a lot of memorable patients who can feel vastly better from doing the trials, it can be life-changing for them.”
And the doctor’s surgery on Kingscote Drive, where he has worked for 10 years, is a dedicated research site, home to two research nurses and a research pharmacist.
Dr Kerrane has led teams which have helped trial pioneering improved drugs to treat diabetes.
He added: “I’ve been involved in clinical trials and medical research for 10 years, the previous partner at Layton had done medical research since the 1980s, and I took it over as he headed towards retirement.
“We’ve built up a good reputation over the years for recruiting to time and target and providing high quality data.”
Now Dr Kerrane has been invited to a special event at BMA House in London, the home of the British Medical Association, on February 4, after “personally driving” the research agenda within the NHS.
He is one of a selection of “leading” principal investigators, whose work will be celebrated, having been invited by Dame Sally Davies, the chief medical officer and chief scientific adviser in the Department of Health.
He added: “It’s a pleasant surprise to be invited.”